Light dosimetry measurements during ALA-PDT of Barrett's oesophagus

Photodiagnosis and Photodynamic Therapy

Volumn 3, Issue 1, 2006, Pages 19-26

  Stringer, M R ^a   Kelty, C J ^b   Ackroyd, R ^b   Brown, S B ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

PDT dose; Photobleaching; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FIBER OPTICS; HUMAN; LIGHT EXPOSURE; LIGHT SCATTERING; OXIDATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL DETECTION;

EID: 33644914471     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1572-1000(05)00155-9     Document Type: Article

References (37)

1. R.C. Haggitt Barrett's esophagus, dysplasia, and adenocarcinoma Hum Pathol 25 1994 982 993
2. D.A. Lieberman, M. Oehlke, and M. Helfand Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy Am J Gastroenterol 92 1997 1293 1297
3. C. Winters Jr., T.J. Spurling, and S.J. Chobanian Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease Gastroenterology 92 1987 118 124
4. R.E. Sampliner Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus Am J Gastroenterol 97 2002 1888 1895
5. W.A. Williamson, F.H. Ellis Jr., and S.P. Gibb Effect of antireflux operation on Barrett's mucosa Ann Thorac Surg 49 1990 537 541
6. L.J. Brandt, R.L. Blansky, and D.R. Kauvar Repeat laser therapy of recurrent Barrett's epithelium: success with anacidity Gastrointest Endosc 41 1995 267
7. H. Barr, N. Stone, and B. Rembacken Endoscopic therapy for Barrett's oesophagus Gut 54 2005 875 884
8. B.F. Overholt, M. Panjehpour, and J.M. Haydek Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients Gastrointest Endosc 49 1999 1 7
9. J.C. Kennedy, and R.H. Pottier Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy J Photochem Photobiol B 14 1992 275 292
10. R. Ackroyd, N. Brown, and D. Vernon 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study Photochem Photobiol 70 1999 656 662
11. H. Barr, C.J. Tralau, and P.B. Boulos The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury Photochem Photobiol 46 1987 795 800
12. R. Ackroyd, N.J. Brown, and M.F. Davis Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo-controlled trial Gut 47 2000 612 617
13. K.K. Wang, L.M. WongKeeSong, and P.K. Nijhawan Does non-dysplastic Barrett's epithelium respond better to mucosal ablation? Gastroenterology 114 1998 A700
14. C.J. Kelty, R. Ackroyd, and N.J. Brown Comparison of high- vs. low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus Surg Endosc 18 2004 452 458
15. L. Gossner, M. Stolte, and R. Sroka Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid Gastroenterology 114 1998 448 455
16. C.J. Kelty, R. Ackroyd, and N.J. Brown Endoscopic ablation of Barrett's oesophagus - a randomised controlled trial of photodynamic therapy (PDT) versus argon plasma coagulation (APC) Aliment Pharmacol Ther 20 2004 1289 1296
17. T. Okunaka, H. Kato, and C. Conaka Photodynamic therapy of esophageal carcinoma Surg Endosc 4 1990 150 153
18. B.F. Overholt, R.C. DeNovo, M. Panjehpour, and M.G. Petersen A centering balloon for photodynamic therapy of esophageal cancer tested in a canine model Gastrointest Endosc 39 1993 782 787
19. H. Barr, N.A. Shepherd, and T. Dix Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX Lancet 348 1996 584 585
20. R. Bays, G. Wagnieres, and D. Robert Light dosimetry for photodynamic therapy in the esophagus Lasers Surg Med 20 1997 290 303
21. 2) quantification techniques: in situ fluorescence microsampling versus tissue chemical extraction Photochem Photobiol 74 3 2001 453 460
22. K.R. Diamond, P.P. Malysz, J.E. Hayward, and M.S. Patterson Quantification of fluorophore concentration in vivo, using two simple fluorescence-based measurement techniques J Biomed Opt 10 2 2005 1 10
23. W.M. Star Light dosimetry in vivo Phys Med Biol 42 1997 763 787
24. S.J. Madsen, C.-H. Sun, B.J. Tromberg, and H. Hirschberg Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy Lasers Surg Med 29 2001 406 412
25. A. Dimofte, T.C. Zhu, S.M. Hahn, and R.A. Lustig In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer Lasers Surg Med 31 2002 305 312
26. M.J. Niedre, C.S. Yu, M.S. Patterson, and B.C. Wilson Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid Br J Cancer 92 2005 298 304
27. H.J. Van Staveren, J.F. Beek, and J.W.H. Ramaekers Integrating sphere effect in whole bladder wall photodynamic therapy: I. 532 nm versus 630 nm optical irradiation Phys Med Biol 39 1994 947 959
28. E.J. Hudson, M.R. Stringer, and F. Cairnduff The optical properties of skin tumours measured during superficial photodynamic therapy Lasers Med Sci 9 1994 99 103
29. K. König, H. Schneckenburger, A. Rück, and R. Steiner In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins J Photochem Photobiol B: Biol 18 1993 287 290
30. R. Sorensen, V. Iani, and J. Moan Kinetics of photobleaching of nude mice exposed to different fluence rates of red light Photochem Photobiol 68 1998 835 840
31. D.J. Robinson, R.S. de Bruijn, and N. van der Veen Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and fluence rate and the resulting biological effect Photochem Photobiol 67 1 1998 140 149
32. E.J. Hudson, M.R. Stringer, H.J. Van Staveren, and M.A. Smith The development of radio-opaque, isotropic, fibre optic probes for light dosimetry studies in photodynamic therapy Phys Med Biol 38 1993 1529 1536
33. R. Rotomskis, S. Bagdonas, and G. Streckyte Spectroscopic studies of photobleaching and photoproduct formation of porphyrins used in phototherapy J Photochem Photobiol B: Biol 33 1996 61 67
34. S. Bagdonas, L.-W. Ma, and V. Iani Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study Photochem Photobiol 72 2 2000 186 192
35. P. Collins, D.J. Robinson, and M.R. Stringer The variable response of plaque psoriasis after a single treatment with topical 5-aminoleavulinic acid photodynamic therapy Br J Dermatol 137 1997 743 749
36. K. Svanberg, T. Andersson, and D. Killander Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation Br J Dermatol 130 6 1994 743 751
37. M. Kriegmair, R. Baumgartner, and R. Knuchel Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence J Urol 155 1 1996 105 109